ArticleCancer management and research2020

Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma.

Lingdun Zhuge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.